| 8090- | KAE, | A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound |
| - | Review, | Nor, | NA |
| 8091- | KAE, | Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT-29 |
| 8092- | KAE, | Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells |
| - | in-vitro, | Colon, | HCT116 | - | in-vitro, | Colon, | DLD1 |
| 8093- | KAE, | Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 8095- | KAE, | Kaempferol: A Key Emphasis to Its Anticancer Potential |
| - | Review, | Var, | NA |
| 8096- | KAE, | 5-FU, | Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway |
| - | in-vitro, | CRC, | HCT8 | - | in-vitro, | CRC, | HCT8 |
| 8097- | KAE, | The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells |
| - | in-vitro, | CRC, | LS174T |
| 8098- | KAE, | Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | HCC, | HUH7 |
| 8099- | KAE, | LT, | CHr, | Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells |
| - | in-vitro, | Lung, | A549 |
| 8100- | KAE, | Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways |
| - | in-vitro, | Cerv, | HeLa |
| 8101- | KAE, | Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway |
| - | vitro+vivo, | ESCC, | KYSE150 | - | vitro+vivo, | ESCC, | Eca109 |
| 8102- | KAE, | Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study |
| - | vitro+vivo, | GC, | MKN-28 | - | vitro+vivo, | GC, | SGC-7901 | - | in-vitro, | GC, | GES-1 |
| 8103- | KAE, | The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions |
| - | in-vitro, | HCC, | HUH7 |
| 8104- | KAE, | A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: Role of NF-κB inhibition and Nrf2 activation |
| - | Review, | Nor, | NA |
| 8105- | KAE, | Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review |
| - | Review, | Var, | NA |
| - | in-vitro, | Melanoma, | A375 |
| - | in-vitro, | Ovarian, | A2780S |
| 8058- | KAE, | A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone |
| - | Trial, | Nor, | NA |
| 8071- | KAE, | Cellular reprogramming and signaling control by kaempferol in colorectal cancer |
| - | Review, | CRC, | NA |
| 8059- | KAE, | Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway |
| - | in-vitro, | Cerv, | KB |
| 8060- | KAE, | Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells |
| - | in-vitro, | CRC, | HT-29 |
| 8061- | KAE, | Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | OVCAR-3 |
| 8062- | KAE, | A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer |
| - | Study, | Ovarian, | NA |
| 8063- | KAE, | Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0/G1 cell cycle arrest and modulation of MEK/ERK and STAT3 pathways |
| - | in-vitro, | Ovarian, | NA |
| 8064- | KAE, | Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | SNU-213 |
| 8065- | KAE, | Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | CRC, | HCT116 |
| 8066- | KAE, | Rad, | Radiosensitization of non-small cell lung cancer by kaempferol |
| - | in-vivo, | Lung, | A549 |
| 8067- | KAE, | Cisplatin, | Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin |
| - | in-vitro, | HNSCC, | NA |
| 8068- | KAE, | TRAIL/rTRAIL, | Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis |
| - | in-vitro, | Colon, | NA |
| 8069- | KAE, | Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia |
| - | in-vivo, | AD, | NA |
| 8070- | KAE, | Kaempferol: Paving the path for advanced treatments in aging-related diseases |
| - | Review, | AD, | NA |
| 8072- | KAE, | Natural defense against colorectal cancer: the effects of kaempferol on epigenetics, apoptosis, inflammation, oxidative stress, and cell proliferation |
| - | Review, | CRC, | NA |
| - | Review, | Nor, | NA |
| 8074- | KAE, | Dose-dependent tuning of HSP70-Beclin-1 by kaempferol governs autophagy and chemosensitivity |
| - | in-vitro, | SCC, | KYSE150 | - | in-vitro, | SCC, | KYSE450 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 |
| 8075- | KAE, | QC, | Systematic review on anticancer potential of Kaempferol and quercetin against lung, breast, and colorectal cancers with emphasis on in vitro and in vivo studies |
| - | Review, | Var, | NA |
| 8076- | KAE, | Kaempferol suppresses prostate cancer metastasis and tumor angiogenesis via disrupting the LIMK1/Cofilin pathway |
| - | in-vivo, | Pca, | NA |
| 8077- | KAE, | Kaempferol exerts anti-colorectal cancer effects through its multi-target mediated glucose metabolism remodeling |
| - | in-vitro, | CRC, | NA |
| 8078- | KAE, | Kaempferol induces mitophagy and disrupts iron metabolism via SFXN2 leading to apoptosis in multiple myeloma cells |
| - | in-vitro, | Mye, | NA |
| 8079- | KAE, | Endoplasmic Reticulum Stress-Mediated Apoptosis Induced by Kaempferol in Colorectal Cancer Cells |
| - | in-vitro, | CRC, | DLD1 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HUH7 | - | in-vitro, | Cerv, | HeLa |
| 8080- | KAE, | Hepatoprotective Effect of Kaempferol—A Review |
| - | Review, | Nor, | NA |
| 8081- | KAE, | The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer |
| - | Review, | BC, | NA |
| 8082- | KAE, | ART/DHA, | SK, | Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review |
| - | Review, | Cerv, | NA |
| 8083- | KAE, | Kaempferol stimulation of autophagy regulates the ferroptosis under the oxidative stress as mediated with AMP-activated protein kinase |
| - | vitro+vivo, | Nor, | HepG2 |
| 7827- | KAE, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 8053- | KAE, | Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies |
| - | Review, | AD, | NA |
| 8054- | KAE, | Kaempferol Improves Alzheimer's Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4/AKR1C3 Signaling Pathway |
| - | vitro+vivo, | AD, | NA |
| 8055- | KAE, | Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review |
| - | Review, | Var, | NA |
| 8056- | KAE, | Kaempferol: advances in biosynthesis, molecular mechanisms, and therapeutic applications |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA |
| 8057- | KAE, | Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans |
| - | Human, | Nor, | NA |
| 8108- | L-Orn, | Safety assessment of L-ornithine oral intake in healthy subjects: a systematic review |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid